Global Biopreservation Market 2018 Forecast to 2023 - A $2.4 Billion Market Opportunity - ResearchAndMarkets.com

DUBLIN--()--The "Global Biopreservation Market - Segmented by Products, Services, Biospecimens, Application, End-users, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global biopreservation market accounted for a value of USD 2,406 million in 2017 and is estimated to grow at a CAGR of about 8.3%, during the forecast period.

Healthcare spending continues to rise faster than the economic growth in most countries, maintaining a trend that has been observed over decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, UK, and Asia-Pacific, has also contributed to the maximum share of GDP that is being utilized in healthcare expenditure. In 2009, the United States had the highest health expenditure per capita (approximately USD 7,960), and a similar trend was also recorded in 2015.

Countries like Norway and Switzerland were also the next big spenders on health, per capita. And with growing technological advancements in biopreservation and healthcare equipment, along with the cost-effectiveness of these instruments, a major share of healthcare spending is going to be in this domain. Factors like increasing life-expectancy and increasing patients with communicable and non-communicable diseases are major factors that have contributed to the growth of the market.

And the other factors, such as increasing advancements in R&D, adoption of in-house sample storage in hospitals and labs, and investments in biobanks and personalized medicine are increasing the growth of the biopreservation market.

Key Developments in the Market

  • February 2018: BioLife Solutions executed OEM Agreement with MilliporeSigma.
  • July 2017: Cesca Therapeutics acquired the cell processing systems of SynGen.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Biolife Solutions Inc.
  • Cesca Therapeutics Inc.
  • Lifeline Scientific Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Biocision LLC
  • Custom Biogenic Systems Inc.
  • Core Dynamics Ltd
  • Princeton Cryotech Inc.
  • VWR International

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/fqzgg4/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology